Taiwan Strait: Beijing Moves Third Carrier Group Into Contested Waters as Washington Weighs Response
FORMER INSIDERS.
CURRENT INTELLIGENCE.
Five careers. Over 140 years of combined time inside the decisions you read about afterward. Pick your briefing.

Carlson Davidson
Founder & Editor-in-Chief • Former Senior Advisor, National Security Council
Carlson Davidson served under two administrations as a senior advisor on national security, briefing presidents on Russia, China, and the shifting balance of global power. A Harvard Kennedy School alumnus and former State Department operative, he built this network to deliver the caliber of intelligence that used to be reserved for the Situation Room. His flagship newsletter sets the editorial line for the entire network. He does not speculate. He reports what the rest of the press corps is afraid to print.
LATEST BRIEFS
NSC Split: White House Divided on Sanctions Package as European Allies Break Ranks
The Quad Is Dead. Here Is What Replaces It — and Why Beijing Is Already Two Moves Ahead

Gen. Victor Marlowe (Ret.)
Former Four-Star General • Pentagon Strategy & Defense Economics
Four-star general. Thirty-seven years in uniform, three combat tours, and a decade overseeing the largest procurement budgets in Pentagon history. Marlowe did not just command forces — he decided where the money went. Which systems got funded. Which programs got buried. He understands the defense-industrial complex not as a talking point, but as a $886-billion machine he personally helped operate. He now writes about where that money is moving, what it is building, and what it means for the companies — and the investors — positioned on either side of those decisions.
LATEST BRIEFS
$14.2 Billion Hypersonic Contract Quietly Reshuffled: Three Primes In, Two Out — Here Is Who Won
Pentagon Accelerates Dark Eagle Timeline by 14 Months: What It Signals for the Missile Defense Supply Chain
The F-35 Sustainment Crisis Nobody Is Talking About — and the $400B Question Behind It

Dr. Eleanor Vance
Former Senior Health Policy Advisor • Biotech & Pharmaceutical Economics
Twenty years inside the institutions that decide what medicine you have access to — and what it costs. Dr. Vance served as a senior health policy advisor in two administrations, sat on FDA advisory panels, and spent a decade tracking pharmaceutical lobbying before most people knew the industry outspent defense contractors on Capitol Hill. Ph.D. in public health economics from Johns Hopkins. She does not write about wellness trends. She follows the money: who is funding what, who is blocking what, and what breakthrough treatments are being buried under regulatory red tape because they threaten the wrong balance sheet.
LATEST BRIEFS
The $6,200 Cancer Drug That Costs $14 to Manufacture: Inside the Pricing Anatomy of Oncology's Dirtiest Secret
FDA Fast-Track Denied: A Promising Alzheimer's Compound Blocked After Lobbying Surge From Three Major Patent Holders
Medicare Negotiation Fallout: Five Drug Classes Where Prices Will Shift — and What Smart Money Is Doing Now

Marcus Chen
Former NSA Operations • Cybersecurity & AI Threat Intelligence
Formerly NSA Tailored Access Operations. Marcus Chen ran offensive cyber campaigns against state-level adversaries before the term ‘cyberwar’ had political currency. MIT dropout turned DARPA consultant, he was the technical reviewer the White House called when the machines started making decisions faster than the generals could. He now covers the AI arms race, critical infrastructure vulnerabilities, and the cybersecurity companies building the next generation of digital defense — separating the firms that will dominate the sector from the ones burning through venture capital with nothing to show for it.
LATEST BRIEFS
APT41 Targeting Defense Primes: Inside the Campaign That Breached Three Tier-1 Contractors in 90 Days
Pentagon Approves First Autonomous Targeting Authority for Naval Drone Swarms — the AI Firms Behind the Code
The Chip Blockade Is Failing: How Beijing Built a Parallel Semiconductor Pipeline — and Who Profits

Sarah Reeve
Former Wall Street Strategist • Federal Reserve & Commodities Analysis
Fifteen years on Wall Street, including a stint on the New York Fed's advisory committee, followed by a decade as an independent commodities strategist trusted by family offices and sovereign wealth funds. Reeve does not predict markets — she reads the institutional signals that move them. When the Fed changes a single word in a statement, she knows what it means six months before CNBC catches on. Her newsletter covers gold, hard assets, central bank policy, and the macro forces that determine whether your portfolio grows or gets quietly eroded by decisions made in rooms you were never invited into.
LATEST BRIEFS
Between the Lines: What the Fed's April Statement Actually Told Institutional Traders — In Three Words
Central Banks Bought More Gold in Q1 Than Any Quarter Since 1967. Here Is the Strategy They Are Not Announcing.
The Dollar's Quiet Slide: Why Smart Money Is Rotating Into Hard Assets — and What Retail Investors Are Missing